DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
New Fortress Energy
NFE
Precision Drilling
PDS
Hutchmed (China)
HCM
Dorian LPG
LPG
US Stock MarketDetailed Quotes
ZURA Zura Bio
- 2.550
- +0.050+2.00%
Close Dec 30 16:00 ET
- 2.510
- -0.040-1.57%
Post 19:53 ET
166.50MMarket Cap-3.91P/E (TTM)
2.580High2.260Low792.13KVolume2.530Open2.500Pre Close1.96MTurnover1.94%Turnover RatioLossP/E (Static)65.29MShares6.35052wk High1.09P/B104.21MFloat Cap2.00052wk Low--Dividend TTM40.87MShs Float37.550Historical High--Div YieldTTM12.80%Amplitude2.000Historical Low2.477Avg Price1Lot Size
Zura Bio Stock Forum
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
Zura Bio, a clinical-stage immunology company, announced its scheduled presentation at EULAR 2024 in Vienna from June 12-15. The company will unveil data on tibulizumab (ZB-106), a dual-pathway antibody targeting IL-17A and BAFF, focusing on its potential for treating Sjogren's syndrome and rheumatoid arthritis. The data aims to ...
Zura Bio (NASDAQ:ZURA), Piper Sandler, a prestigious investment firm, has initiated coverage on the biotechnology company, assigning it an "overweight" rating and setting an ambitious price target of $26. This optimistic forecast suggests a potential upside of 462.77% from the stock's previous close. The announcement by Piper Sandler und...
SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.1%),Peter Kolchinsky(5.1%), etc.
NEWS
Zura Bio Raises $112.5M Through Private Placement Deal
NEWS
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
No comment yet